This summary covers the issue of September 7, 2006. Featured are articles on DNA repair by ERCC1 in non–small-cell lung cancer and adjuvant chemotherapy, soluble endoglin and other circulating antiangiogenic factors in preeclampsia, enoxaparin versus unfractionated heparin in elective PCI, cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412; review articles on social anxiety disorder and on oncogene-induced cell senescence; a clinical problem-solving article describing more than meets the eye; and Perspective articles on T-cell costimulation, on going beyond disease to address disability, and on learning clinical judgment as a medical student.
I'm Dr. Joshua Schwimmer, a nephrologist and internal medicine physician in New York City. • Kidney Notes was the first active nephrology blog. (Trivia: Kidney Notes is so old that the National Library of Medicine still uses it as an example of how to formally cite blogs.) • Professionally, you can find me at Kidney.nyc. • Kidney Notes is for educational purposes only, not medical advice. Consult qualified health care professionals. See disclaimer.
Thursday, September 7, 2006
New England Journal of Medicine Audio Summary for September 7, 2006
From the NEJM: